When a freezer storing COVID-19 vaccines in Seattle failed, hundreds of people showed up in the middle of the night to get vaccinated before the doses spoiled.
The incident highlighted a few hallmarks of the vaccine rollout so-far: high demand, limited supplies and complicated storage and delivery logistics.
On Friday, Johnson & Johnson released promising data for their single-dose shot, which could be a game changer for getting shots into arms, if approved. Their formula has less onerous shipping and storage requirements compared to the Pfizer vaccine, and would cut out the need for multiple appointments.
Increasing accessibility to COVID-19 vaccines is a major concern across the board, but it is especially important in the context of addressing racial disparities across the country. Black and Latinx communities have been hit disproportionately hard by the virus but are getting vaccinated at lower rates than their white peers.
Despite many Americans clamoring for appointments, there’s rising concern about the number of people who turn down the vaccine when it’s made available to them. MPR News host Kerri Miller spoke with two physicians about the rollout, access and refusal of COVID-19 vaccines.
Dr. Krutika Kuppalli is an an assistant professor in the Division of Infectious Diseases at the Medical University of South Carolina and vice chair of the Infectious Diseases Society of America’s Global Health Committee.
Dr. Nikhila Juvvadi is chief clinical officer at The Loretto Hospital in Chicago.
Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts, Spotify or RSS
To listen to the full conversation you can use the audio player above.
Grow the Future of Public Media
MPR News is supported by Members. Gifts from individuals power everything you find here. Make a gift of any amount today to become a Member!